Recombinant C-Reactive Protein: A Potential Candidate for the Treatment of Cutaneous Leishmaniasis of BALB/c Mice Caused by Leishmania major.

Seyedeh Noushin ZahediSeyed Hossein HejaziMaryam BoshtamFarahnaz AminiHossein FazeliMahdieh SarmadiMahsa RahimiHossein Khanahmad

Published in: Acta parasitologica (2020)

The results indicate a potential therapeutic role for hrCRP in improving cutaneous leishmaniasis due to Leishmania major in mice models. The healing was in a stage-dependent manner.

Keyphrases

high fat diet induced
wild type
type diabetes
insulin resistance
risk assessment
smoking cessation